Neonates, especially those who are premature or have compromised immune systems, are at increased risk for invasive fungal infections. These infections can be life-threatening and require prompt, aggressive treatment. Voriconazole is sometimes used in neonates when other antifungal agents are ineffective or when the specific fungal pathogen is known to be susceptible to voriconazole.
